Skip to content

Change in AR at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$595M-35.7%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$700K-95.2%
TG Therapeutics logo
TG TherapeuticsTGTX
$86.42M+41.8%
Merck & Co. logo
Merck & Co.MRK
$272.5M+347%
AbbVie logo
AbbVieABBV
-$87M-106%
Incyte logo
IncyteINCY
$27.03M+187%

Other financials

Income statement

See full
Net income-$147.9M-38.9%
EPS (diluted)-$0.73-15.9%

Balance sheet

See full
Cash & equivalents$902.1M+26.4%
Total debt$72.0K-26.5%
Total equity$852.6M+20.5%
Total assets$957.0M+23.3%

Cash flow

See full
Operating cash flow-$95.1M+14.1%
CapEx$8.0K-96.0%
Free cash flow-$95.1M+14.2%

Valuation

See full
Market cap$7.26B+74.2%
Enterprise value$6.35B+89.7%

Returns & leverage

See full
Return on equity-64.8%+2.5pp
Debt / equity0.0×
Current ratio9.1×-2.1×

Where this comes from

Reported directly by Immunovant, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunovant, Inc.'s change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immunovant, Inc.'s change in AR?
Immunovant, Inc. (IMVT) reported change in AR of -$563K in Q1 2026.
How has Immunovant, Inc.'s change in AR changed year-over-year?
Immunovant, Inc.'s change in AR decreased by 562.4% year-over-year, from -$85K to -$563K.
What is the long-term trend for Immunovant, Inc.'s change in AR?
Over 4 years (2022 to 2026), Immunovant, Inc.'s change in AR has grown at a -45.7% compound annual growth rate (CAGR), from $11.63M to -$1.01M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.